Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |